Company calls BIOLASE Website Representations False and Misleading CERRITOS, CA -- (Marketwired) -- 03/24/14 -- Millennium Dental Technologies Inc. (MDT) -- the world leader in dentist satisfaction of its signature value propositions LANAP(R) and LAPIP(TM) protocols -- has issued comments regarding false and misleading representations made by Biolase Inc. regarding a former MDT management level employee. The company considers the statements made by Biolase regarding MDT former vice president of global sales and marketing, Brian Jaffe, to be false and misleading. Biolase has published on its website the following representation, "Prior to joining Biolase, Jaffe served as vice president of global sales at Millennium Dental Technologies during 2013, growing the periodontal laser sales reach by realigning and expanding the U.S. sales force and expanding international distribution." http://www.biolase.com/Pages/vp-sales-marketing.aspx Robert H. Gregg, DDS, co-founder and president of Millennium Dental Technologies stated, "Jaffe did very little that could be considered growing the periodontal laser sales reach of the LANAP(R) protocol for periodontitis treatment, or the LAPIP(TM) protocol for treating ailing and failing implants." Dr. Gregg said, "In fact, Jaffe was a block in the process of growing our domestic sales, as indicated by the poor sales results compared to the prior year." Delwin K. McCarthy, DDS, chief technology officer and co-founder of Millennium Dental Technologies stated, "Brian is a really neat guy, but unfortunately, even with bringing two independent sales reps on board, his actions did nothing to realign or expand sales within our U.S. sales force. The reality is sales slightly contracted under his watch." Mark Monaghan, MDT CEO commented, "It is simply not true that Brian Jaffe did anything to expand international distribution." Monaghan continued, "Brian's past experience included broad international distribution and we were hoping that he would do the same for MDT. Unfortunately, in the short six months of his tenure with us, he had no impact on international sales including lack of follow-up with existing international resellers." Dr. Gregg added, "Jaffe fought and resisted key marketing and pricing initiatives, which ultimately resulted in his departure. But he does have a noteworthy tennis forehand." Dr. Gregg quipped. NOTE TO EDITORS: Additional information can be viewed at http://www.LANAP.com CONTACT: Mark Monaghan CEO 562-860-2908 mmonaghan@LANAP.com Dr. Delwin McCarthy Chief Technology Officer 562-860-2908 dmccarthy@LANAP.com Dr. Robert Gregg President 562-860-2908 rgregg@LANAP.com
Company calls BIOLASE Website Representations False and Misleading
Press spacebar to pause and continue. Press esc to stop.